Organ sparing to cure stage IV rectal cancer: A case report and review of literature

Table 1 Demographic data

Patient No.	Age (yr)	Sex	BMI	Comorbid conditions	ASA score	CEA level	Rectal tumor			Liver metastasis
							Size (mm)	Distance to anal verge (mm)	staging	Nb of lesions	bilobar	Size of the largest metastasis
1	65	M	31	HTN, DM, Smocking	2	14000	40	30	T3N1	15	1	73
2	78	M	29	HTN	2	55	25	40	T3N1	1	0	46
3	58	M	23	DM, Smocking	3	18	18	25	T3N1	3	1	25
4	77	M	24	HTN	2	134	30	50	T3N1	2	0	42
5	68	M	26	Myasthenia	2	7	30	38	T3N0	5	1	70
6	58	M	25	Smocking	2	1	40	25	T3N1	13	1	20
7	59	M	27	COPD	2	27	40	20	T3N1	6	1	26
8	64	F	23	HTN	2	281	25	35	T3N1	2	0	52

BMI: Body mass index; ASA: American society of anesthesiologists; CEA: Carcinoembryonic antigen; HTN: Hypertension; DM: Diabetes mellitus; COPD: Chronic obstructive pulmonary disease.

Table 2 Oncologic and surgical treatment

Patient No.	Preoperative treatment	Liver surgery			Rectal strategy				Postoperative treatment
		Type	PVE	Two stage	Restaging	Type	Delay1	Histologic analysis
1	Folfox × 12 then CRT	Major hepatectomy	1	0	T0N0	LE	9	T0R0	0
2	Folfiri × 6 then CRT	Segmentectomy	0	0	T0N0	LE	11	T0R0	Patient’s refusal
3	Folfox × 10 then CRT	Major hepatectomy	0	0	T1N0	LE	9	T0R0	0
4	Folfox × 4 then CRT	Major hepatectomy	0	0	T0N0	LE	12	T2R0 (TRG1)	Folfiri-cetux × 8
5	Folfirinox × 8 then CRT	Major hepatectomy + Tum + RF	1	1	T2N0	LE	11	T0R0
6	Folfirinox × 6 then CRT	Major hepatectomy + Tum + RF	1	1	T1N0	LE	10	T2R0 (TRG1)	Folfox × 6
7	Folfirinox × 4 then CRT	Tum + RF	0	0	T0N0	WW	-	-	Folfox × 8
8	Folfiri cetux × 6 then CRT	Tum + segmentectomy	0	0	T0N0	WW	-	-	Folfox × 6

¹Delay between the end of chemoradiation and rectal surgery. CRT: Chemoradiation; PVE: Portal vein embolization; RF: Radiofrequence; LE: Local excision; WW: Watch and wait; TRG: Tumor regression grade.